After a 36-week lead-in period, participants were randomized to either continue tirzepatide or switch to placebo for 52 weeks
Pharmaceutical-Grade Retatrutide from Canada Clinical trials show 24.2% average fat loss with this triple-action GLP-1/GIP/glucagon receptor agonist
When you combine behavior change, mindset shifts, and develop self-belief, then the GLP-1 can work its magic
Samples were drawn from Panels LTD online panel of over 30,000 active Israeli members, supplemented with cellphone and landline contacts and Hebrew-language outreach to Haredi communities
We're still learning how they have such broad impact, especially about their anti-inflammatory effects, systemically and in the brain nature.com/articles/d4158 A new feature @Nature, by @marilenharo The GLP-1 drugs are the most important drug class breakthrough in medical history
(3,4) TB500, a fragment of thymosin beta4, interacts with actin dynamics to increase cellular migration and mobility in laboratory models